These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Antiviral treatment reduces risk of hepatocellular carcinoma in patients with hepatitis C virus-related chronic hepatitis and cirrhosis]. Kasahara A; Hiramatsu N Nihon Rinsho; 2011 May; 69 Suppl 4():314-8. PubMed ID: 22096937 [No Abstract] [Full Text] [Related]
24. HCV-related liver cancer in people with haemophilia. Meijer K; Haagsma EB Haemophilia; 2012 Jan; 18(1):17-24. PubMed ID: 21651676 [TBL] [Abstract][Full Text] [Related]
25. Hepatocellular carcinoma. Manns MP; Kubicka S Digestion; 1997; 58 Suppl 1():69-75. PubMed ID: 9225098 [No Abstract] [Full Text] [Related]
26. Hepatocellular carcinoma: status in the era of liver transplantation. Singhal A; Jabbour N J Okla State Med Assoc; 2009 Dec; 102(12):355-61. PubMed ID: 20131731 [No Abstract] [Full Text] [Related]
27. Liver disease: current perspectives on medical and dental management. Golla K; Epstein JB; Cabay RJ Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 Nov; 98(5):516-21. PubMed ID: 15529121 [No Abstract] [Full Text] [Related]
28. Clinical Trial Watch: Reports from the EASL International Liver Congress (ILC), Vienna, April 2015. Gambato M; Villanueva A; Abraldes JG; Altamirano J; Forns X J Hepatol; 2015 Sep; 63(3):753-62. PubMed ID: 26095181 [No Abstract] [Full Text] [Related]
29. [Clinical study on relationship between hepatocellular carcinoma and hepatitis C virus infection in patients with chronic liver disease]. Sata M; Tokeshi S; Nakano H; Majima Y; Tanikawa K Rinsho Byori; 1992 Sep; 40(9):929-34. PubMed ID: 1279247 [TBL] [Abstract][Full Text] [Related]
31. The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospect. Marotta F; Vangieri B; Cecere A; Gattoni A Clin Ter; 2004 May; 155(5):187-99. PubMed ID: 15344567 [TBL] [Abstract][Full Text] [Related]
32. [Hepatocellular cancer with a background of liver cirrhosis]. Zhuravlev VA; Agalakov VI Klin Med (Mosk); 1996; 74(2):2-5. PubMed ID: 8772088 [No Abstract] [Full Text] [Related]
35. Management of small focal liver lesions in a cirrhotic liver: discussion. Reynaert H; Van Vlierberghe H; De Beeck BO; Roskams T Acta Gastroenterol Belg; 2006; 69(2):236-7. PubMed ID: 16929623 [No Abstract] [Full Text] [Related]
36. [Is there a place for arterial chemoembolization of the liver in the treatment for hepatocellular carcinoma?]. Trinchet JC; Mathieu D; Beaugrand M Gastroenterol Clin Biol; 1995 Dec; 19(12):967-9. PubMed ID: 8729406 [No Abstract] [Full Text] [Related]
38. [Inflammation and Hepatic Fibrosis, Then Hepatocellular Carcinoma]. Kwon OS; Choi SH; Kim JH Korean J Gastroenterol; 2015 Dec; 66(6):320-4. PubMed ID: 26691189 [TBL] [Abstract][Full Text] [Related]
39. Hepatocellular carcinoma (an approach to the study of risk factors in human cancer). London WT Ric Clin Lab; 1978; 8(4):232-6. PubMed ID: 216070 [TBL] [Abstract][Full Text] [Related]
40. Clinical outcomes of chronic hepatitis C patients related to baseline liver fibrosis stage: a hospital-based linkage study. Huang Y; de Boer WB; Adams LA; MacQuillan G; Bulsara MK; Jeffrey GP Intern Med J; 2015 Jan; 45(1):48-54. PubMed ID: 25371273 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]